Analysis Tools
immune system
|
• between 3 - 9 months of age, 14 of 200 transgenic mice developed tumors that appeared to arise from immature thymic T cells
|
|
• transgenic mice are highly susceptible to passive systemic anaphylaxis and die within 30 minutes of a challenge with DNP coupled to BSA 1 day after an i.v. injection with 5 ug of monoclonal anti-DP IgE, while all wild-type mice survived
• however, transgenic mice are not more susceptible to passive cutaneous anaphylaxis
|
|
• transgenic CD4+ T cells produce more Il-5 than wild-type cells in response to anti-CD3 stimulation; secretion is inhibited by neutralization of Il-9 by addition of an antibody to the culture
|
homeostasis/metabolism
|
• a dose of 1 ug of N-methyl-N-nitrosourea induced tumors in all transgenic mice but did not induce tumors in wild-type mice
|
neoplasm
|
• between 3 - 9 months of age, 14 of 200 transgenic mice developed tumors that appeared to arise from immature thymic T cells
|
|
• a dose of 1 ug of N-methyl-N-nitrosourea induced tumors in all transgenic mice but did not induce tumors in wild-type mice
|
endocrine/exocrine glands
|
• between 3 - 9 months of age, 14 of 200 transgenic mice developed tumors that appeared to arise from immature thymic T cells
|
hematopoietic system
|
• between 3 - 9 months of age, 14 of 200 transgenic mice developed tumors that appeared to arise from immature thymic T cells
|
